GAITHERSBURG, Md., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 21, 2019 at 5:00 pm (Eastern Time) to discuss the financial results for the fourth quarter and full year 2018, recent business developments, financial outlook for full year 2019, and revenue guidance for the first quarter of 2019.

This conference call can be accessed live by telephone or by webcast:

Live Teleconference Information :
Dial in number: (855) 766-6521
International dial in: (262) 912-6157
Conference ID: 2299983
 
Live Webcast Information :
Visit https://edge.media-server.com/m6/p/ow37uwh9 for the live webcast feed.

A replay of the call can be accessed on Emergent’s website emergentbiosolutions.com under “ Investors .”

About Emergent BioSolutions Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats. We aspire to be a Fortune 500 company recognized for protecting and enhancing life, driving innovation, and living our values. Additional information about the company may be found at www.emergentbiosolutions.com . Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact: Robert G. Burrows Vice President, Investor Relations 240-631-3280 BurrowsR@ebsi.com

Media Contact: Lynn Kieffer Vice President, Corporate Communications 240-631-3391 KiefferL@ebsi.com